🔎 Trials Near Me

Beranda › Karsinoma Sel Skuamosa Kepala dan Leher › Florida › Miami

Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di Miami, FL

14 studi untuk Karsinoma Sel Skuamosa Kepala dan Leher mencari peserta di lokasi sekitar Miami (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Menerima pesertaFase 1
  • Exelixis Clinical Site #47, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05176483

A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer

Menerima pesertaFase 3
  • University of Miami Sylvester Comprehensive Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07276399

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Menerima pesertaFase 2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Usia 18 hingga 79 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04671667

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Menerima pesertaFase 1
  • Sylvester Comprehensive Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 21 Sep 2026 · NCT05983432

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Menerima pesertaFase 1/2
  • Sylvester Comprehensive Cancer Center - Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT05267626

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

Menerima pesertaFase 2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT02734537

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Menerima pesertaFase 1/2
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06657222

Intralesional Chemotherapy (IC): Cisplatin + Epinephrine

Menerima pesertaFase 2
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07392580

Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer

Menerima pesertaFase 2/3
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT04333537

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

Menerima pesertaFase 2/3
  • Miami Cancer Institute, Miami
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT05893888

A Study of VET3-TGI in Patients With Solid Tumors

Menerima pesertaFase 1
  • University of Miami, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 7 Apr 2026 · NCT06444815

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Menerima pesertaFase 1
  • University of Miami - Sylvester Comprehensive Cancer Center, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Feb 2026 · NCT06778863

HPV DNA-Guided Radiotherapy De-intensification of Head and Neck Squamous Cell Carcinoma

Menerima pesertaFase 2
  • Miami Cancer Institute, Miami
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Feb 2026 · NCT05962242

Uji klinis Karsinoma Sel Skuamosa Kepala dan Leher di kota lain

Studi lain di Miami

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.